Fig. 3: Metabolomics profiling of plasma samples obtained from COVID-19 survivors 6 months after discharge and healthy control subjects.
From: Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
A Heatmap visualization of significantly different altered metabolites (DEMs) in COVID-19 survivors at 6 months after discharge and in healthy control subjects. Metabolites included in the heatmap showed a fold-change >2 or <0.5 and p value (t test) of <0.05. The color bar represents the relative intensity of identified proteins from −6 to 6. B Boxplots of six elected metabolites that significantly differed between COVID-19 survivors at 6 months after discharge and healthy control subjects. For the healthy control group, n = 30; for the non-severe group, n = 30; for the severe group, n = 24. 5-HETE 5-hydroxyeicosatetraenoic acid; 12-HETE 12-hydroxyeicosatetraenoic acid; LTB4 leukotriene B4; 15-oxoETE 15-oxoeicosatetraenoic acid; PGE2 prostaglandin E2; TG triglycerides.
